Perspective: Making Treatment Decisions for Crohn's Disease in 2025-Key Considerations

Area of Science:

• Gastroenterology and immunology
• Inflammatory bowel disease research

Background:

• Crohn's disease treatment strategies are continually advancing.
• Recent research has significantly impacted clinical decision-making for managing this chronic condition.

Purpose of the Study:

• To review nine key studies from the past decade influencing Crohn's disease treatment.
• To provide a personal perspective on optimal management strategies for luminal Crohn's disease.

Main Methods:

• Narrative, opinion-based review of selected original studies.
• Focus on studies significantly impacting luminal Crohn's disease treatment approaches.

Main Results:

• Early, appropriate treatment with advanced therapies or surgery is recommended for moderate to severe Crohn's disease.
• Anti-tumor necrosis factor (TNF) therapy is an effective first-line option, requiring monitoring and potential co-therapy.
• Ustekinumab and risankizumab are suitable second-line options for anti-TNF non-responders.
• Multidisciplinary approaches are crucial for managing complications like intra-abdominal abscesses.
• Dietary interventions show promise as future disease-modifying strategies.

Conclusions:

• Personalized treatment algorithms incorporating advanced therapies, surgery, and multidisciplinary care are essential for Crohn's disease.
• Long-term remission is achievable with appropriate initial therapy.
• Further research into biomarkers and dietary interventions is needed to refine treatment personalization.